More precise and pervasive cybersecurity threat modeling during manufacturers’ development of medical devices – and also during the regulatory product review process – is critical for risk mitigation, says Kevin Fu, new acting director of medical device cybersecurity at the FDA.- Read More – InfoRiskToday.com RSS Syndication


By |2021-04-09T20:18:45-04:00April 9th, 2021|